110 related articles for article (PubMed ID: 9194387)
1. [Autologous BMT for B-lineage adult ALL patients using ex vivo purging with monoclonal antibodies].
Mizuta S; Kawano A
Rinsho Ketsueki; 1997 May; 38(5):422-5. PubMed ID: 9194387
[No Abstract] [Full Text] [Related]
2. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
[No Abstract] [Full Text] [Related]
3. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
4. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow transplantation after in vitro purging with monoclonal antibodies and complement in acute lymphoblastic leukemia.
Perez-Oteyza J; Larana JG; Brieva J; Roldan E; Odriozola J; Maldonado M; Otheo E; Munoz A; Bootello A; Navarro JL
Prog Clin Biol Res; 1992; 377():163-8. PubMed ID: 1438412
[No Abstract] [Full Text] [Related]
6. Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients.
Canals C; Puntí C; Picón M; Amill B; Tugues D; Sanchez T; Badell I; Pardo N; Ortega J; Vivancos P
Prog Clin Biol Res; 1992; 377():289-96. PubMed ID: 1438427
[No Abstract] [Full Text] [Related]
7. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
8. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
[No Abstract] [Full Text] [Related]
9. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
10. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shin HJ; Chung JS; Cho GJ
Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
[No Abstract] [Full Text] [Related]
11. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute lymphoblastic leukemia.
Hoelzer D
Semin Hematol; 1994 Jan; 31(1):1-15. PubMed ID: 8122133
[No Abstract] [Full Text] [Related]
13. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC).
Houtenbos I; Bracho F; Davenport V; Slack R; van de Ven C; Suen Y; Killen R; Shen V; Cairo MS
Bone Marrow Transplant; 2001 Jan; 27(2):145-53. PubMed ID: 11281383
[TBL] [Abstract][Full Text] [Related]
14. Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.
van Heeckeren WJ; Vollweiler J; Fu P; Cooper BW; Meyerson H; Lazarus HM; Simic A; Laughlin MJ; Gerson SL; Koç ON
Br J Haematol; 2006 Jan; 132(1):42-55. PubMed ID: 16371019
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow purging prior to autologous transplantation.
Zingsem J; Stahlhut K; Serke S; Zeiler T; Weisbach V; Zimmermann R; Siegert W; Eckstein R
Infusionsther Transfusionsmed; 1992 Dec; 19(6):288-90. PubMed ID: 1295636
[TBL] [Abstract][Full Text] [Related]
16. Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia.
Vervoordeldonk SF; van den Berg H; von dem Borne AE; van Leeuwen EF; Slaper-Cortenbach IC
J Hematother; 1997 Oct; 6(5):495-500. PubMed ID: 9368186
[TBL] [Abstract][Full Text] [Related]
17. In-vivo purging with the anti-CD20 antibody rituximab along with standard allogeneic peripheral blood stem cell transplantation (PBSCT) for relapsed childhood pre-B acute lymphoblastic leukaemia (ALL).
Ansari SH; Irfan M; Farzana ; Panjwani VK; Shamsi TS
J Coll Physicians Surg Pak; 2006 Jan; 16(1):67-8. PubMed ID: 16441995
[TBL] [Abstract][Full Text] [Related]
18. [Monoclonal antibody and purging].
Ueda R; Morishima Y
Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016
[No Abstract] [Full Text] [Related]
19. Bone marrow purging with etoposide/methylprednisolone in patients undergoing autologous bone marrow transplantation.
Pineiro L; Fay J; Collins R; Herzig G
Prog Clin Biol Res; 1994; 389():17-21. PubMed ID: 7700899
[No Abstract] [Full Text] [Related]
20. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan).
Deconinck E; Cahn JY; Milpied N; Jouet JP; Vernant JP; Esperou H; Lioure B; Bordigoni P; Leblond V; Troussard X; Caillot D; Cordonnier JM; Hervé P
Bone Marrow Transplant; 1997 Nov; 20(9):731-5. PubMed ID: 9384474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]